PlainRecalls
FDA Drug Moderate Class II Completed

Dr. Reddy's: Ranitidine Capsules 150 mg, Rx a.) 60 count bottles (NDC 55111-129-60) b.) 500 count bottles (NDC 55111-129-05)

Reported: November 13, 2019 Initiated: October 1, 2019 #D-0168-2020

Product Description

Dr. Reddy's: Ranitidine Capsules 150 mg, Rx a.) 60 count bottles (NDC 55111-129-60) b.) 500 count bottles (NDC 55111-129-05)

Reason for Recall

CGMP Deviations: Presence of NDMA impurity detected in product.

Details

Units Affected
N/A
Distribution
Product was distributed to major distributors throughout the United States who may have further distributed the product.
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Dr. Reddy's: Ranitidine Capsules 150 mg, Rx a.) 60 count bottles (NDC 55111-129-60) b.) 500 count bottles (NDC 55111-129-05). Recalled by Dr. Reddy's Laboratories, Inc.. Units affected: N/A.
Why was this product recalled?
CGMP Deviations: Presence of NDMA impurity detected in product.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 13, 2019. Severity: Moderate. Recall number: D-0168-2020.